Patent application number | Description | Published |
20110301065 | IDENTIFYING ANTIGEN CLUSTERS FOR MONITORING A GLOBAL STATE OF AN IMMUNE SYSTEM - Method, system and an article of manufacture for clustering and thereby identifying predefined antigens reactive with undetermined immunoglobulins of sera derived from patient subjects in need of diagnosis of disease or monitoring of treatment. | 12-08-2011 |
20120122720 | MEANS AND METHODS FOR RECOGNIZING THE DEVELOPMENT OF CARDIOVASCULAR DISEASE IN AN INDIVIDUAL - A method of recognizing the development of an Acute Myocardial Infarction (AMI) process in an individual, wherein the method comprises steps of: profiling specific antibody reactivities or biomarkers associated with AMI susceptibility, the profiling comprises steps of: attaching a set of defined antigens to a substrate; obtaining a biological fluid derived specimen from an individual, the specimen containing a specific antibody repertoire; and binding said antibodies of the biological fluid specimen to the attached antigens thereby forming bound antibody antigen complexes; and analyzing results obtained, wherein the presence of the complexes is indicative of AMI. | 05-17-2012 |
20130035254 | DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) - The present invention relates to methods and kits for diagnosing systemic lupus erythematosus (SLE) in a subject. Particularly, the present invention relates to a specific antibody profile useful in diagnosing SLE in a subject. | 02-07-2013 |
20130252839 | MARKERS OF PRIMARY GRAFT DYSFUNCTION - The present invention relates to methods for diagnosing transplant rejection, or a condition associated with transplant rejection, such as, primary graft dysfunction in a subject, to antigen probe arrays for performing such a diagnosis, and to antigen probe sets for generating such arrays. | 09-26-2013 |
20140200159 | IDENTIFYING ANTIGEN CLUSTERS FOR MONITORING A GLOBAL STATE OF AN IMMUNE SYSTEM - Method, system and an article of manufacture for clustering and thereby identifying predefined antigens reactive with undetermined immunoglobulins of sera derived from patient subjects in need of diagnosis of disease or monitoring of treatment. | 07-17-2014 |
20140315740 | ANTIGEN ARRAY AND DIAGNOSTIC USES THEREOF - A method of diagnosing an immune disease, or a predisposition thereto, in a subject is disclosed. The method comprises determining a capacity of immunoglobulins of the subject to specifically bind each antigen probe of an antigen probe set, wherein the antigen probe set comprises a plurality of antigen probes selected from the group consisting of at least a portion of a cell/tissue structure molecule, at least a portion of a heat shock protein, at least a portion of an immune system molecule, at least a portion of a homopolymeric polypeptide, at least a portion of a hormone, at least a portion of a metabolic enzyme, at least a portion of a microbial antigen, at least a portion of a molluscan antigen, at least a portion of a nucleic acid, at least a portion of a plant antigen, at least a portion of plasma molecule, and at least a portion of a tissue antigen, wherein the capacity is indicative of the immune disease or the predisposition thereto, thereby diagnosing the immune disease, or the predisposition thereto, in the subject. | 10-23-2014 |
20140336077 | MEANS AND METHODS FOR RECOGNIZING THE DEVELOPMENT OF CARDIOVASCULAR DISEASE IN AN INDIVIDUAL - A method of recognizing the development of an Acute Myocardial Infarction (AMI) process in an individual, wherein the method comprises steps of: profiling specific antibody reactivities or biomarkers associated with AMI susceptibility, the profiling comprises steps of: attaching a set of defined antigens to a substrate; obtaining a biological fluid derived specimen from an individual, the specimen containing a specific antibody repertoire; and binding said antibodies of the biological fluid specimen to the attached antigens thereby forming bound antibody antigen complexes; and analyzing results obtained, wherein the presence of the complexes is indicative of AMI. | 11-13-2014 |
20140342939 | DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS - The present invention relates to methods and kits for diagnosing systemic lupus erythematosus (SLE) in a subject. Particularly, the present invention relates to a specific antibody profile useful in diagnosing SLE in a subject. | 11-20-2014 |
Patent application number | Description | Published |
20090313413 | METHOD FOR WIRING ALLOCATION AND SWITCH CONFIGURATION IN A MULTIPROCESSOR ENVIRONMENT - A method for wiring allocation and switch configuration in a multiprocessor computer, the method including employing depth-first tree traversal to determine a plurality of paths among a plurality of processing elements allocated to a job along a plurality of switches and wires in a plurality of D-lines, and selecting one of the paths in accordance with at least one selection criterion. | 12-17-2009 |
20120117660 | ACCESS CONTROL FOR SERVER APPLICATIONS - A method, system, and computer program product for access control for a server application provided between a server executing an application and a client. Access control is added to an existing server application (for example, a legacy application) without changing the application or the database. The method includes: capturing a screen from the server application; determining if the screen includes sensitive content; and checking a client user's authorization before sending a screen including sensitive content to the client. Determining if the screen includes sensitive content may include: carrying out text recognition on the screen content; and analyzing the output of the text recognition to identify sensitive content. | 05-10-2012 |
20130212689 | MANAGING NETWORK DATA - A method, system or computer usable program product for masking communication data using context based rules including intercepting a communication between a server and a client by an intermediary, the communication having a recipient, parsing the communication by the intermediary to determine whether a context based alteration rule should be applied, responsive to an affirmative determination, applying the rule to the communication to produce an altered communication with altered data, and sending the altered communication to the recipient so that the altered data in the communication is utilized in a masked manner. | 08-15-2013 |